A toxic protein called amyloid beta is thought to play a key role in the onset of Alzheimer's disease. In healthy people, amyloid beta is degraded by enzymes as it forms. However, in patients with the disease, these enzymes ...
Mar 2, 2016
0
1387
Researchers at the RIKEN Brain Science Institute in Japan have developed a new technique for creating transparent tissue that can be used to illuminate 3D brain anatomy at very high resolutions. Published in Nature Neuroscience, ...
Sep 14, 2015
0
45
Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists ...
May 4, 2015
1
568
Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer's disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these ...
Mar 2, 2015
0
189
(Medical Xpress)—Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found.
May 7, 2013
0
1
Alzheimer's disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing ...
Apr 10, 2012
0
0
(Medical Xpress) -- Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer’s hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the ...
May 2, 2011
0
0
UNC School of Medicine researcher Sarah Cohen, Ph.D., and Ian Windham, a former Ph.D. student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE)—the biggest genetic risk factor for late-onset Alzheimer's ...
Feb 9, 2024
0
64
American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer's medication. According to the company, their experimental drug, donanemab, was shown ...
May 10, 2023
0
11
A recent study revealed that a protein important for neuron communication is associated with patient resistance to Alzheimer's disease and may delay cognitive decline.
Apr 27, 2023
0
8
